Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

PISKORSKI WALTER — Orexigen Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / PISKORSKI WALTER

PISKORSKI WALTER

SVP, Technical Operations at Orexigen Therapeutics, Inc. · on record since Jan 26, 2010

Insider trading activity of PISKORSKI WALTER

Transactions on record: 2; since Apr 27, 2009

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 26, 2010

Figures computed from official regulatory filings — methodology.

Companies where PISKORSKI WALTER has traded

Orexigen Therapeutics, Inc.2 tx · Jan 26, 2010

Track record of PISKORSKI WALTER

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of PISKORSKI WALTER

Co-insiders of PISKORSKI WALTER

ACE HEATHER SOrexigen Therapeutics, Inc.
Arkin MosheOrexigen Therapeutics, Inc.
BAUM CAROL AOrexigen Therapeutics, Inc.
Baupost Group GP, L.L.C.Orexigen Therapeutics, Inc.
BAUPOST GROUP LLC/MAOrexigen Therapeutics, Inc.
BA Venture Partners VII, LLCOrexigen Therapeutics, Inc.
BAVP VII LPOrexigen Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BLAIR JAMES COrexigen Therapeutics, Inc.

BOCK LOUIS COrexigen Therapeutics, Inc.

Booth Mark DOrexigen Therapeutics, Inc.

BREEN DORONOrexigen Therapeutics, Inc.

BYMASTER FRANKLIN POrexigen Therapeutics, Inc.

Cannell Thomas ROrexigen Therapeutics, Inc.

COOPER GRAHAM KOrexigen Therapeutics, Inc.

COWLEY MICHAEL AOrexigen Therapeutics, Inc.

DIXON WENDY LOrexigen Therapeutics, Inc.

DOMAIN ASSOCIATESOrexigen Therapeutics, Inc.

DOMAIN PARTERS VII L POrexigen Therapeutics, Inc.

DOMAIN PARTNERS V LPOrexigen Therapeutics, Inc.

DOVEY BRIAN HOrexigen Therapeutics, Inc.

DP V ASSOCIATES LPOrexigen Therapeutics, Inc.

DP VII ASSOCIATES LPOrexigen Therapeutics, Inc.

DUNAYEVICH EDUARDOOrexigen Therapeutics, Inc.

Endicott David J.Orexigen Therapeutics, Inc.

Flynn Peter DOrexigen Therapeutics, Inc.

Forbes MonicaOrexigen Therapeutics, Inc.

Hagan Joseph POrexigen Therapeutics, Inc.

Halak Brian KOrexigen Therapeutics, Inc.

Honig PeterOrexigen Therapeutics, Inc.

JORN DEBORAOrexigen Therapeutics, Inc.

Kamdar Kim P.Orexigen Therapeutics, Inc.

Keyes Jason AOrexigen Therapeutics, Inc.

KIM DENNIS DOrexigen Therapeutics, Inc.

KLARMAN SETH AOrexigen Therapeutics, Inc.

Klassen PrestonOrexigen Therapeutics, Inc.

KLEINER PERKINS CAUFIELD & BYERS X A LPOrexigen Therapeutics, Inc.

KLEINER PERKINS CAUFIELD & BYERS X B LPOrexigen Therapeutics, Inc.

KPCB X ASSOCIATES LLCOrexigen Therapeutics, Inc.

LACOB JOSEPHOrexigen Therapeutics, Inc.

LANCASTER JAMES C JROrexigen Therapeutics, Inc.

LANDBLOOM RONALD POrexigen Therapeutics, Inc.

Lynch Thomas P.Orexigen Therapeutics, Inc.

MAHAFFY PATRICK JOrexigen Therapeutics, Inc.

M. ARKIN (1999) LTD.Orexigen Therapeutics, Inc.

MCKINNEY ANTHONY AOrexigen Therapeutics, Inc.

Moglia Stephen A.Orexigen Therapeutics, Inc.

MORE ROBERT JOrexigen Therapeutics, Inc.

MOR ISRAELOrexigen Therapeutics, Inc.

NARACHI MICHAELOrexigen Therapeutics, Inc.

POWELL MICHAELOrexigen Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Orexigen Therapeutics, Inc.	Jan 26, 2010	AwardD	85,000	—	—	SEC
Orexigen Therapeutics, Inc.	Apr 27, 2009	AwardD	51,636	—	—	SEC